BSE decided to lower circuit limit of scrips of 12 companies, including those which were hammered in the mid-cap crash yesterday.

Share prices of 20 stocks such as Welspun, Opto Circuit, slumped by 15-32% with Core Education, falling by as much as 66%.

Drug maker Aanjaneya Lifecare today reported 67.96 per cent increase in net profit at Rs 18.93 crore for the first quarter ended June 30, m...

Indian companies raised a total of Rs 5,800 crore during the last fiscal 2011-12 through IPOs - a slump of 82 per cent from the previous ye...

Aanjaneya will raise $ 75 mn by issuing securities and foreign currency convertible bonds to fund its ongoing capex and acquisitions.

"This Aanjaneya itself is also a bit of intriguing stock because it has been rising more or less steadily since its listing back in June 20...

Shares of Aanjaneya Lifecare rose to a new high amid talk that the company is close to acquiring a domestic pharma company in the SME segme...

Net sales of the company for the year ended March 31,2011 rose to Rs 320.25 crore from Rs 161.67 crore during the same period previous fisc...

Bulk drug maker said it has received orders worth Rs 60 cr from Wockhardt and Cipla, for manufacturing cough syrup 'Recodex'.

Out of the 15 companies that hit the secondary market in 2011, nine entities are attracting negative returns in the range of 16-75 per cent.

Aanjaneya Lifecare, which plans to raise Rs 120 crore through initial public offer (IPO), said it will use the proceeds to fuel its expansi...

Drugmaker Aanjaneya Lifecare is planning to tap the capital market to raise around Rs 120 crore in the next few weeks.

Aanjaneya Lifecare Ltd plans to tap the capital market and has filed the draft papers with the SEBI for its IPO.